Conference Call to Follow Release
DENVER, Nov. 3 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, will report its third quarter and nine month financial results on Thursday, November 13, 2008, before the market opens. The Company will host a conference call at 9:00 a.m. EST on the same day.
Dr. Mick Ruxin, Chief Executive Officer, Tom Marcinek, President and Chief Operating Officer, and Darren Craig, Vice President of Finance, will discuss the third quarter and nine-month financial results, as well as major company developments, and will be available to answer questions. The one-hour conference call will be held on November 13, 2008, at 9:00 a.m. EST.
Interested parties are welcome to call the telephone numbers listed below five minutes prior to the start of the conference call. Callers within the U.S. should call: 1-866-789-9224. Callers that are outside of the U.S. should call: 1-706-679-9621. Callers should reference "Global Med Third Quarter Financial Results" to the conference call operator. The conference call ID number will be: 71180318.
An automated replay of the conference call will be available from November 13, 2008 at 11:30 a.m. EST until November 15, 2008 at 11:59 p.m. EST. To access the replay, callers within the U.S. should call: 1-800-642-1687. Callers outside of the U.S. should call: 1-706-645-9291 and enter Global Med's access code of 71180318.
The replay of the conference call will be available from November 15, 2008 onward at Global Med's website at http://www.globalmedtech.com.
About Global Med Technologies, Inc.
Global Med Technologies(R), Inc. is an international medical software company which develops regulated and non-regulated software products and services for the healthcare industry. As a leading provider of blood and laboratory software applications and services, Global Med's products are deployed in 20 countries and serve over 1,600 transfusion centers, blood banks and laboratories.
Global Med's U.S. division, Wyndgate Technologies(R), provides Vein-to-Vein(R) tracking through its Donor Doc(TM), SafeTrace(R), SafeTrace Tx(R) and ElDorado Donor(TM) software products. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply.
Global Med's European subsidiary, Inlog, SA, is a leading provider of donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally. Inlog's products include EdgeBlood*, EdgeTrack*, EdgeCell, EdgeLab and SAPANET.
Global Med's U.S. division, eDonor(R), provides a web-based donor relationship management system that integrates recruitment, scheduling, retention and fulfillment for national as well as local community blood centers and hospitals. eDonor's products and services are designed to complement Global Med's strong line of international blood management and laboratory information software and service solutions.
Global Med's U.S. subsidiary, PeopleMed(R), Inc., provides cost-effective customized software validation, consulting and compliance solutions to hospitals and donor centers.
For more information about Global Med's products and services, please call 800-996-3428 or visit http://www.globalmedtech.com, http://www.peoplemed.com, http://www.inlog.com, http://www.eDonor.com, and http://www.wyndgate.com.
*FDA 510(k) clearance required prior to sales in the U.S.
This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.
|SOURCE Global Med Technologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved